BioMelbourne Network Progressing BioIndustry

12th March - Devices & Diagnostics Lab
Delivering precise and personalised medicine: More

Victorian BioPortal

Looking for Something?

The Victorian BioPortal is the largest online search engine for biotechnology in Victorian with over 2,000 individual listings.

Start your search now

BioMelbourne Network

The Building Global Bridges program provides grants of between $100,000 & $500,000 to Victorian life science companies to develop partnerships with Massachusetts companies in late stage life sciences R&D projects. The program helps Victorian innovation to accelerate, access expertise, develop skills & better reach global markets and international investors. Applications close 17 September 2013.

Building Global Bridges

Circadian announces: US Patent Granted for Soluble VEGFR-3 Traps

28th January, 2015  - 1980 days of patent term adjustment (PTA) awarded extending patent expiry to 22 June 2026- Patent coverage for soluble VEGFR-3 fusion proteins, such as OPT-302- Equivalent patents granted in Europe, Japan, Canada and Australia Circadian Technologies Limited, through its wholly-owned subsidiary Vegenics Pty Ltd, is pleased to announce the grant of US Patent Number 8,940,6... read more…

Peter Lewis of Hydrix appointed a Member of the Order of Australia (AM) for services to ‘International Trade, Biotechnology and ICT’.

27th January, 2015  Peter Lewis, a high profile figure in the Australian biomedical devices industry was was appointed a Member of the Order of Australia (AM) on the 2015 Australia Day Honours list for his services to ‘International Trade, Biotechnology and ICT’. Mr Lewis is an accomplished senior executive with over 25 years’ experience leading growth strategies for technology based companies... read more…

SIENNA READIES FOR NEXT PHASE OF GROWTH - CHIEF EXECUTIVE OFFICER DR KERRY HEGARTY TO STEP DOWN

22nd January 2015.  Sienna Cancer Diagnostics Ltd, a Melbourne-based biotechnology company, focused on developing novel in vitro diagnostics tests for cancer, has today announced that Managing Director and Chief Executive Officer Dr Kerry Hegarty will step down from her position, after ten years in the role.Her resignation comes on the heels of recent transformational events for Sienna Cancer D... read more…

Murdoch Childrens-led mobile health APP, PEERSTM, a top 20 finalist in the OzAPP awards

20th January 2015.  Murdoch Childrens Research Institute has been named as a top 20 finalist in the 2014 – 15 OzAPP Awards for the development of a tablet-based app called PEERSTM. The OzAPP awards bring together the best mobile, web and cloud based app concepts in the Asia Pacific region. PEERSTM (Paediatric evaluation of emotions relationships and socialization) will be the first clinically-... read more…

Invion Announces Positive Interim Data from its Phase II Clinical Trial of Oral INV102 (Nadolol) in Smoking Cessation

19 January 2015.  Invion Limited (ASX: IVX) is pleased to announce positive interim data from its phase II double-blind placebo-controlled randomised clinical trial in patients with chronic cough or established COPD who are trying to quit smoking but have failed multiple times previously. The interim data is generated from an assessment of sputum (phlegm) samples collected from patients upon r... read more…

Phosphagenics Appoints Dr Ross Murdoch as Chief Executive Officer

14 January 2015.  After an extensive global search, Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY) is pleased to announce the appointment of Dr Ross Murdoch as CEO. Dr Murdoch has more than 25 years of experience leading and managing the strategic, scientific and operational aspects of product research, development and commercialisation across the healthcare, ... read more…

Academia-industry Alliance Towards Autoimmune Disease

12 January 2015.   Monash University announced today that it has signed a research collaboration agreement with Janssen-Cilag Pty Ltd. (Janssen), one of the Janssen Pharmaceutical companies of Johnson & Johnson. The collaboration, facilitated by Johnson & Johnson Innovation, Asia Pacific, will focus on ground-breaking research at Monash University to develop potential new medicines to treat au... read more…

Melbourne Cancer Biotech Sienna Strikes First Big Deal with US Firm

8 January 2015.   Melbourne biotechnology start-up Sienna Cancer Diagnostics, which is backed by ex-Macquarie boss Allan Moss, has signed its first deal with an American pathology company paving the way for a potential float this year. The unlisted company, which was a beneficiary of the now defunct Commercialisation Australia grant program, will seek to raise $10 million. Chief executive Ke... read more…

Premier Daniel Andrews finalises ministers' portfolios

4 December 2014.   The BioMelbourne Network welcomes the new Victorian Government Ministry, as announced today by Premier Daniel Andrew. We look forward to working Ministers in supporting innovative businesses and entrepreneurship in the biotechnology and medical technology sector. In particular, we look forward to collaborating with Adem Somyurek the Minister For Small Business, Innovation an... read more…

Innovation Key to Jobs and Growth Under Labor

28 November 2014.  While the Napthine Government cut funding to science, technology, engineering and innovation by 60 per cent, Innovation and job creation will be key to Victorian jobs and growth under an Andrews Labor Government.Labor will establish the Premier’s Jobs and Investment Panel, using the unique insight of the private sector on how to invest $500 million to create high-skill, high-... read more…

VCGS Signs a Deal with Illumina for Non-invasive Prenatal Testing

27 November 2014.  The Victorian Clinical Genetics Services (VCGS), a subsidiary of the Murdoch Childrens Research Institute in Melbourne has signed an agreement with leading genomics company Illumina, to allow VCGS to offer its own Non-Invasive Prenatal Test (NIPT) based on next-generation sequencing technology.The deal adds to the VCGS prenatal testing portfolio. Currently VCGS provides mater... read more…

LBT Completes Australian Clinical Trials of APAS® Technology

26 November 2014.  Medical technology company LBT Innovations Limited (ASX: LBT) has completed two comprehensive clinical trials of its pioneering culture-plate analysis technology, the Automated Plate Assessment System (APAS®), at the laboratories of Healthscope Pathology in Melbourne and Adelaide.The trials successfully tested the efficacy of the APAS technology in detecting and reporting the... read more…

Global Kinetics Corporation Achieves Key Milestones for Expansion

6 November 2014.  Swedish regulatory affairs veteran and former head of European Medicine Agency to join Global Kinetics Board Key EU patent granted covering lead Parkinson’s KinetiGraph™ (PKG™) technology Aggressive expansion agenda for leading mobile health technology company Australian mobile health technology company Global Kinetics Corporation announced today that it has appointed... read more…

Completion of Rights Issue

6 November 2014.  MELBOURNE, Australia: Circadian Technologies Limited (ASX:CIR, OTCQX:CKDXY)  is pleased to confirm the completion  of  the  two for five  fully underwritten  non- renounceable rights issue (Rights Issue) announced on 6 October 2014.The Rights Issue offered up to 19,453,313 new shares at $0.175 per share to eligible shareholders. Eligible shareholders were those with a register... read more…

Victoria election 2014: Labor pledges $60m contribution for biomedical research centre

2 November 2014. The Victorian Labor Party says it will contribute $60 million to Australia's first research and education centre for biomedical engineering if it wins the November 29 state election.Opposition Leader Daniel Andrews said the investment in the Aikenhead Centre for Medical Discovery at St Vincent's Hospital would bring together doctors, scientists and researchers to help Victoria ... read more…

Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane® to be PBS Listed for Metastatic Pancreatic Cancer

31 October 2014. • ABRAXANE plus gemcitabine to be PBS listed for Australian patients with metastatic pancreatic cancer from 1 November • ABRAXANE plus gemcitabine significantly improves survival outcomes • A new standard of care now available for all patients with metastatic pancreatic cancer Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is pleased to announ... read more…

Accelerating commercialisation outcomes in Australia

31 October 2014.  Australian businesses and innovators will have access to the full suite of support streams to usher in a new wave of competitiveness and productivity growth under the Australian Government’s $484.2 million Entrepreneurs’ Infrastructure Programme.Minister for Industry Ian Macfarlane today launched the final part of the package, the Accelerating Commercialisation stream, which i... read more…

New $200 million Biotechnology Venture Capital Fund secured in Melbourne

31 October 2014.  Minister for Technology Gordon Rich-Phillips today announced the establishment of the $200 million Biotechnology Translation Fund in conjunction with fund manager Brandon Capital Partners, the manager of the Medical Research Commercialisation Fund (MRCF).Minister Rich-Phillips said the Victorian Coalition Government has secured the fund's headquarters for Melbourne with a cont... read more…

d3 Medicine welcomes a new Director - Dr. Julie Bullock PharmD

30 October 2014.   Dr. Bullock has over 10 years of drug development experience within the FDA. Dr Bullock's pastappointments include Clinical Pharmacology Team Leader and Senior Clinical PharmacologyReviewer. Her regulatory experience was focused in the therapeutic areas of hematology/oncologyand coagulation. She has significant experience in facilitating pediatric drug development,streamlini... read more…

2014 Prime Minister's Prizes for Science

29 October 2014. Joint release with the Hon. Tony Abott MP, Prime Minister Tonight, we recognise and celebrate the accomplishments of Australian science and Australian scientists. Australia has a proud history in science and a wealth of scientific talent. Our people are full of great ideas. The Commonwealth Government will continue to provide the strong support that science needs to find th... read more…